Related Experiment Video
Updated: Jul 19, 2026
09:27
Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
Published on: May 6, 2020
Mass vaccination against hepatitis B: the French example
1Department of Bacteriology-Virology-Hygiene, Limoges, France. francois.denis@unilim.fr
Current Topics in Microbiology and Immunology
|September 23, 2006
Summary
Hepatitis B vaccination coverage in France is low due to safety concerns, hindering disease control. Reinstating public confidence in hepatitis B vaccines is crucial for successful universal immunization programs.
Area of Science:
- Public Health
- Vaccinology
- Epidemiology
Background:
- Mainland France is a low endemicity area for hepatitis B, while French overseas territories face intermediate to high endemicity.
- Hepatitis B vaccination strategies evolved from targeted high-risk groups to universal preadolescent/adolescent and infant immunization.
- Concerns linking hepatitis B vaccination to neurological disorders significantly reduced vaccine uptake.
Purpose of the Study:
- To analyze the impact of vaccination policies on hepatitis B control in France.
- To assess current hepatitis B vaccination coverage rates.
- To highlight the importance of public confidence in vaccine safety and efficacy.
Main Methods:
- Review of hepatitis B vaccination policies and coverage data in France.
- Analysis of trends in hepatitis B virus (HBV) vaccination uptake.
- Evaluation of the impact of safety concerns on vaccination programs.
Main Results:
- Hepatitis B virus (HBV) vaccination coverage in children under 13 is only 23.3%.
- Current vaccination rates are insufficient to significantly reduce hepatitis B prevalence.
- Declined vaccine use affects both pediatric and adult populations.
Conclusions:
- Achieving effective hepatitis B control in France requires higher vaccination coverage.
- Restoring public and healthcare professional confidence in hepatitis B vaccine safety is paramount.
- Successful universal immunization hinges on addressing safety concerns and improving vaccine acceptance.
Related Concept Videos
01:51Vaccinations
Overview
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...